ProQR Therapeutics N.V.
PRQR
$1.47
-$0.06-3.92%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -44.80% | -4.69% | -44.35% | -377.04% | -27.58% |
| Total Depreciation and Amortization | 11.62% | 10.50% | 3.71% | 0.10% | -4.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 382.93% | 947.39% | 93.26% | 298.41% | -70.34% |
| Change in Net Operating Assets | 101.77% | -1,195.84% | -392.66% | 73.08% | 29.37% |
| Cash from Operations | 23.07% | -56.04% | -130.00% | -92.16% | -1.20% |
| Capital Expenditure | 20.15% | -331.81% | 37.15% | 60.13% | 70.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 20.15% | 79.40% | -101.08% | 60.13% | 98.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 46.38% | -137.55% | 2.20% | 0.34% | 2.41% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -58.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.69% | -100.92% | -4.24% | -9.56% | -15.67% |
| Foreign Exchange rate Adjustments | 166.54% | -98.16% | 79.07% | -1,553.07% | -744.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.33% | -126.33% | -231.33% | -97.80% | 50.40% |